Researchers find hope in diabetes battle

Sep 16, 2006

Canadian researchers have found what they hope is a magic bullet in combating diabetes.

McMasters University scientists are crediting extra use by the commonly prescribed Rosiglitazone for the hope of cutting the diabetes epidemic in half, the Hamilton Spectator said.

Widely used to treat type 2 diabetes, Rosiglitazone has been found effective for those at highest risk because of genetics, age or obesity, making it what researchers call the first line of defense for diabetes.

The results of the $25 million study were presented Friday at the annual meeting of the European Association for the Study of Diabetes in Copenhagen.

Copyright 2006 by United Press International

Explore further: Food supplements plus cash to poor families reduces rates of child malnutrition in Niger

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Throwing a loop to silence gene expression

47 minutes ago

All human cells contain essentially the same DNA sequence – their genetic information. How is it possible that shapes and functions of cells in the different parts of the body are so different? While every cell's DNA contains ...

Time to take notice and tackle heart failure

57 minutes ago

Experts have sounded a call to action for policy makers at local, national, and international levels to promote heart failure prevention, improve heart failure awareness among healthcare professionals, ensure ...

Mirabegron for overactive bladder: Added benefit not proven

1 hour ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

User comments : 0